Published in Am J Dis Child on April 01, 1987
Serologic response to varicella-zoster membrane antigens measured by direct immunofluorescence. J Infect Dis (1974) 4.41
Measles outbreak in a fully immunized secondary-school population. N Engl J Med (1987) 2.75
Prevention of varicella by zoster immune globulin. N Engl J Med (1969) 2.57
Enzyme-linked immunosorbent assay for susceptibility to varicella. J Infect Dis (1983) 2.03
Separation of infectious Varicella-Zoster virus from human embryonic lung fibroblasts. Virology (1967) 1.85
Cell-free varicella-zoster virus in cultured human melanoma cells. J Gen Virol (1979) 1.64
Antibody response following measles-mumps-rubella vaccine under conditions of customary use. JAMA (1983) 1.60
Zoster immune globulin. A further assessment. N Engl J Med (1974) 1.57
Observations on the growth of varicella-zoster virus in human diploid cells. J Gen Virol (1973) 1.48
Enzyme-linked immunosorbent assay for evaluation of immunity to measles virus. J Clin Microbiol (1984) 1.47
Varicella-Zoster Immunoglobulins during Varicella, Latency, and Zoster. J Infect Dis (1975) 1.47
Chickenpox--examining our options. N Engl J Med (1991) 1.41
Recent advances in varicella-zoster virus infection. Ann Intern Med (1999) 1.41
Complement-enhanced neutralizing antibody response to varicella-zoster virus. J Infect Dis (1979) 1.40
Lack of evidence of transmission of HIV-1 to family contacts of HIV-1 infected children. Clin Pediatr (Phila) (1998) 1.40
Risk factors for invasive group A streptococcal infections in children with varicella: a case-control study. Pediatr Infect Dis J (1996) 1.28
Zoster, reinfection or activation of latent virus? Observations on the antibody response. Am J Med (1970) 1.28
Specific immunoglobulin M enzyme-linked immunosorbent assay for confirming the diagnosis of measles. J Clin Microbiol (1986) 1.27
Risk of herpes zoster in children with leukemia: varicella vaccine compared with history of chickenpox. Pediatrics (1986) 1.19
Prevention of varicella in high risk children: a collaborative study. Pediatrics (1972) 1.16
Passive immunization against varicella-zoster infections and other modes of therapy. J Infect Dis (1973) 1.15
Effect of early immunization on antibody response to reimmunization with measles vaccine as demonstrated by enzyme-linked immunosorbent assay (ELISA). Pediatrics (1984) 1.12
Varicella-zoster infections in pregnancy. JAMA (1967) 1.08
Steroid therapy and varicella. J Pediatr (1972) 1.08
Safe handling of vaccines. Pediatrics (1991) 1.03
Unrecognized human immunodeficiency virus type 1 infection in a cohort of transfused neonates: a retrospective investigation. Pediatrics (1995) 1.03
Safety and immunogenicity of Haemophilus influenzae type b polysaccharide and polysaccharide diphtheria toxoid conjugate vaccines in children 15 to 24 months of age. J Pediatr (1987) 1.03
Impact of revaccinating children who initially received measles vaccine before 10 months of age. Pediatrics (1986) 1.00
Children hospitalized for varicella: a prevaccine review. J Pediatr (1996) 0.99
Varicella vaccine--where are we? Pediatrics (1986) 0.99
Zoster in infancy: failure to maintain virus latency following intrauterine infection. J Pediatr (1981) 0.96
Fetal and neonatal varicella-zoster infections. Semin Perinatol (1983) 0.95
Administration of live varicella vaccine to children wtih leukaemia. Lancet (1982) 0.95
Epidemiological standardization of a test for susceptibility to mumps. J Infect Dis (1984) 0.93
Measles control in the United States: problems of the past and challenges for the future. Clin Microbiol Rev (1995) 0.91
Mycoplasma, amnionitis, and respiratory distress syndrome. JAMA (1969) 0.90
Evaluation of the pertussis components of diphtheria-tetanus-pertussis vaccine. Pediatrics (1983) 0.89
Evaluation of a live attenuated mumps vaccine (Jeryl Lynn). With observations on the optimal time for testing serologic response. Am J Dis Child (1969) 0.88
Varicella-like illness caused by live varicella vaccine in children with acute lymphocytic leukemia. Pediatrics (1987) 0.86
Management of varicella exposure in a neonatal intensive care unit. JAMA (1989) 0.86
Commentary: protection against varicella. Pediatrics (1977) 0.85
Susceptibility of hospital personnel to varicella-zoster virus. J Infect Dis (1984) 0.85
Herpes zoster in children with acute lymphocytic leukemia. Am J Dis Child (1988) 0.85
Outbreak of varicella in a newborn intensive care nursery. Am J Dis Child (1984) 0.84
Antibodies to the three major glycoproteins of varicella-zoster virus: search for the relevant host immune response. J Infect Dis (1987) 0.83
Placental transfer of varicella-zoster antibody. Pediatrics (1966) 0.82
Bivalent influenza vaccine in children with cancer. J Infect Dis (1977) 0.81
Varicella-zoster virus vaccine. JAMA (1978) 0.80
Visceral involvement by herpes simplex virus in eczema herpeticum. Am J Dis Child (1968) 0.80
Varicella in day care centers. Rev Infect Dis (1986) 0.80
Should patients with zoster receive zoster immune globulin? JAMA (1975) 0.80
Herpes simplex infection of the newborn. Am J Dis Child (1972) 0.80
Rapid diagnosis of varicella-zoster infections by agar-gel diffusion. J Infect Dis (1972) 0.79
Anti-bovine antibody in human sera as a cause of nonspecificity in enzyme immunoassay. J Clin Microbiol (1987) 0.79
Ineffectiveness of isolation of patients as a method of preventing the spread of mumps. Failure of the mumps skin-test antigen to predict immune status. N Engl J Med (1968) 0.79
Parotitis in children who had previously received mumps vaccine. Pediatrics (1972) 0.79
Zoster in children. Am J Dis Child (1968) 0.78
Complete spectrum of the varicella congenital defects syndrome in 5-year-old child. Pediatr Infect Dis (1984) 0.78
Varicella vaccine: the crossroads is where we are not! Pediatrics (1978) 0.78
Virus burden in human immunodeficiency virus type 1-infected children: relationship to disease status and effect of antiviral therapy. Pediatrics (1991) 0.78
Abscess in newborn infants caused by Mycoplasma. Pediatrics (1970) 0.78
Safety and immunogenicity of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine (PRP-D) in infants. J Infect Dis (1987) 0.77
American Academy of Pediatrics Committee on Infectious Diseases: Prevention of hepatitis B virus infections. Pediatrics (1985) 0.76
Establishment by enzyme-linked immunosorbent assay of seronegative range for herpes simplex virus and cytomegalovirus antibodies and evaluation of heterologous responses to live varicella vaccine. J Clin Microbiol (1988) 0.76
Clinical manifestations of varicella-zoster virus infections in human immunodeficiency virus-infected children. Am J Dis Child (1993) 0.76
Possible mechanisms for maintaining immunity to varicella-zoster virus. Clinical observations. Am J Dis Child (1970) 0.76
Interview with Philip A. Brunell: contagion and varicella-zoster virus. Pediatr Infect Dis (1983) 0.76
The antigens of varicella-zoster virus. J Immunol (1972) 0.75
Inhibition of oral shedding of herpes simplex virus by cytosine arabinoside. J Infect Dis (1973) 0.75
Varicella vaccine update. West J Med (1988) 0.75
Enzyme-linked immunosorbent assay for detection of antibody to human herpesvirus 6. Clin Diagn Lab Immunol (1997) 0.75
A gel-precipitin test for the diagnosis of varicella. Bull World Health Organ (1971) 0.75
Oral acyclovir treatment of chickenpox in normal adolescents. J Pediatr (1992) 0.75
Value of skin test for mumps. N Engl J Med (1969) 0.75
Measles vaccine. Pediatr Ann (1990) 0.75
Effect of the antiviral drug, cytosine arabinoside, on the developing nervous system. Pediatr Res (1974) 0.75
A new technique for staining cover slips for fluorescence microscopy. Appl Microbiol (1967) 0.75
Prevention of pertussis--are we failing? Pediatrics (1985) 0.75
Recent developments in childhood immunizations. Tex Med (1986) 0.75
Varicella-zoster virus infection of diploid and chemically transformed guinea-pig embryo cells: factors influencing virus replication. J Gen Virol (1981) 0.75
Propagation of varicella-zoster virus in a diploid strain of embryonic thyroid cells from the rhesus monkey. J Infect Dis (1972) 0.75
Management of neonates born to mothers with group B streptococcus colonization. J Perinatol (1997) 0.75
Varicella vaccination: where do we go from here? Hosp Pract (1980) 0.75
Non-streptococcal pharyngitis. Pediatr Infect Dis (1985) 0.75
American Academy of Pediatrics. Committee on Infectious Diseases. Recommendations for using pneumococcal vaccine in children. Pediatrics (1985) 0.75
Pneumonia in the neonatal intensive care unit. Diagnosis by quantitative bacterial tracheal aspirate cultures. J Perinatol (1994) 0.75
Mumps antibody: placental transfer and disappearance during the first year of life. Pediatrics (1970) 0.75
Effect of live attenuated mumps vaccine virus on the expression of tuberculin sensitivity. J Pediatr (1972) 0.75
Childhood infectious diseases in adults. Tex Med (1981) 0.75
Enteroviral infections. Pediatr Infect Dis (1985) 0.75
Immunization practice--1983. Trans Assoc Life Insur Med Dir Am (1985) 0.75
Letter: Zoster immune globulin shortage! Pediatrics (1974) 0.75
Administration of varicella vaccine to children with leukemia. Biken J (1984) 0.75
Varicella exposure time. Pediatrics (1988) 0.75
Prevention and treatment of neonatal herpes. Pediatrics (1980) 0.75
Susceptibility of medical students to mumps: comparison of serum neutralizing antibody and skin test. Pediatrics (1971) 0.75
Meningoencephalitis in a neonate congenitally infected with human immunodeficiency virus type 1. J Pediatr (1992) 0.75
The prevention of infectious diseases by immunization. J Allergy Clin Immunol (1987) 0.75
Managing childhood chickenpox: cost implications. Pharmacoeconomics (1993) 0.75
Prevention of pertussis, Haemophilus and varicella infections. Pediatr Infect Dis (1985) 0.75